Cardiff Oncology (CRDF) Treasury Shares (2022 - 2026)

Cardiff Oncology has reported Treasury Shares for 4 years, with the latest figure at $61000.0 in Q4 2025.

• Quarterly Treasury Shares changed 0.0% year-over-year to $61000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $61000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $61000.0, changed 0.0% from the prior year.
• Treasury Shares held at $61000.0 in Q4 2025 per CRDF's latest filing, from $61000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $61000.0 in Q4 2023 and troughed at $60600.0 in Q4 2022.
• A 4-year average of $60890.9 and a median of $61000.0 in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares gained 0.66% in 2023, then changed 0.0% in 2024.
• Over 4 years, Treasury Shares stood at $60600.0 in 2022, then rose by 0.66% to $61000.0 in 2023, then changed by 0.0% to $61000.0 in 2024, then changed by 0.0% to $61000.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $61000.0, $61000.0, and $61000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.